Chemed (CHE) Stock Price
Chemed Price
Revenue has compounded at 4.9% per year over the past 19 years to 2.53 B USD. Earnings per share have grown at 12.7% per year over the last 19 years. Chemed's net margin stands at 10.5%, down from 12.6% several years earlier. Chemed currently offers a dividend yield of about 0.41%. The payout ratio is around 12% of earnings. The dividend has grown at 12.4% per year over the past 19 years. Analysts set a median price target of 587.52 USD, implying 10.2% above the current price. Of 8 analysts, 6 rate the stock a buy — an overall Buy consensus. The stock trades about 45% above its 52-week low.
Chemed stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Chemed over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Chemed stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Chemed's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Chemed Price |
|---|---|
| 8/19/2026 | 533.09 USD |
| 8/18/2026 | 536.11 USD |
| 8/14/2026 | 532.88 USD |
| 8/13/2026 | 537.17 USD |
| 8/12/2026 | 541.02 USD |
| 8/11/2026 | 537.14 USD |
| 8/10/2026 | 552.09 USD |
| 8/7/2026 | 552.72 USD |
| 8/6/2026 | 549.41 USD |
| 8/5/2026 | 538.74 USD |
| 8/4/2026 | 537.92 USD |
| 8/3/2026 | 540.57 USD |
| 7/31/2026 | 532.25 USD |
| 7/30/2026 | 534.79 USD |
| 7/29/2026 | 539.20 USD |
| 7/27/2026 | 512.52 USD |
| 7/23/2026 | 503.01 USD |
| 7/22/2026 | 503.52 USD |
| 7/21/2026 | 504.10 USD |
| 7/20/2026 | 513.68 USD |
| 7/17/2026 | 510.03 USD |
| 7/16/2026 | 501.51 USD |
| 7/15/2026 | 492.65 USD |
| 7/14/2026 | 491.89 USD |
| 7/13/2026 | 492.50 USD |
| 7/10/2026 | 488.59 USD |
| 7/9/2026 | 490.46 USD |
| 7/8/2026 | 484.98 USD |
| 7/7/2026 | 485.37 USD |
| 7/6/2026 | 482.77 USD |
| 7/2/2026 | 489.66 USD |
| 7/1/2026 | 480.87 USD |
| 6/30/2026 | 465.74 USD |
| 6/29/2026 | 458.54 USD |
| 6/26/2026 | 463.28 USD |
| 6/25/2026 | 453.15 USD |
| 6/24/2026 | 447.29 USD |
| 6/23/2026 | 444.11 USD |
| 6/22/2026 | 435.40 USD |
| 6/18/2026 | 437.73 USD |
| 6/17/2026 | 435.42 USD |
| 6/16/2026 | 428.21 USD |
| 6/15/2026 | 415.00 USD |
| 6/12/2026 | 418.77 USD |
| 6/11/2026 | 427.39 USD |
| 6/10/2026 | 439.47 USD |
| 6/9/2026 | 446.26 USD |
| 6/8/2026 | 439.13 USD |
| 6/5/2026 | 441.41 USD |
| 6/4/2026 | 433.56 USD |
| 6/3/2026 | 424.86 USD |
| 6/2/2026 | 420.25 USD |
| 6/1/2026 | 422.60 USD |
| 5/29/2026 | 441.70 USD |
| 5/28/2026 | 439.29 USD |
| 5/27/2026 | 439.76 USD |
| 5/26/2026 | 437.52 USD |
| 5/22/2026 | 439.55 USD |
| 5/21/2026 | 440.81 USD |
| 5/20/2026 | 439.01 USD |
| 5/19/2026 | 440.05 USD |
| 5/18/2026 | 441.62 USD |
| 5/15/2026 | 434.53 USD |
| 5/14/2026 | 426.21 USD |
| 5/13/2026 | 424.04 USD |
| 5/12/2026 | 419.65 USD |
| 5/11/2026 | 421.43 USD |
| 5/8/2026 | 424.26 USD |
| 5/7/2026 | 425.82 USD |
| 5/6/2026 | 424.56 USD |
| 5/5/2026 | 427.55 USD |
| 5/4/2026 | 425.92 USD |
| 5/1/2026 | 422.16 USD |
| 4/30/2026 | 424.98 USD |
| 4/29/2026 | 423.94 USD |
| 4/28/2026 | 421.10 USD |
| 4/27/2026 | 422.72 USD |
| 4/24/2026 | 421.11 USD |
| 4/23/2026 | 382.97 USD |
| 4/22/2026 | 373.15 USD |
| 4/21/2026 | 373.79 USD |
| 4/20/2026 | 385.77 USD |
| 4/17/2026 | 384.61 USD |
| 4/16/2026 | 382.88 USD |
| 4/15/2026 | 377.61 USD |
| 4/14/2026 | 376.41 USD |
| 4/13/2026 | 387.62 USD |
| 4/10/2026 | 385.84 USD |
| 4/9/2026 | 390.85 USD |
| 4/8/2026 | 395.25 USD |
| 4/7/2026 | 388.95 USD |
| 4/6/2026 | 386.36 USD |
| 4/2/2026 | 380.60 USD |
| 4/1/2026 | 377.57 USD |
| 3/31/2026 | 377.74 USD |
| 3/30/2026 | 374.09 USD |
| 3/27/2026 | 368.59 USD |
| 3/26/2026 | 371.95 USD |
| 3/25/2026 | 371.95 USD |
| 3/24/2026 | 374.02 USD |
| 3/23/2026 | 373.89 USD |
| 3/22/2026 | 373.42 USD |
| 3/20/2026 | 377.99 USD |
| 3/19/2026 | 377.99 USD |
| 3/18/2026 | 384.83 USD |
| 3/17/2026 | 383.21 USD |
| 3/16/2026 | 399.34 USD |
| 3/15/2026 | 398.33 USD |
| 3/13/2026 | 401.87 USD |
| 3/12/2026 | 401.87 USD |
| 3/11/2026 | 399.55 USD |
| 3/10/2026 | 402.72 USD |
| 3/9/2026 | 400.76 USD |
| 3/8/2026 | 403.47 USD |
| 3/6/2026 | 407.88 USD |
| 3/5/2026 | 407.88 USD |
| 3/4/2026 | 412.16 USD |
| 3/3/2026 | 410.99 USD |
| 3/2/2026 | 424.16 USD |
| 3/1/2026 | 421.40 USD |
| 2/27/2026 | 410.01 USD |
| 2/26/2026 | 410.01 USD |
| 2/25/2026 | 396.63 USD |
| 2/24/2026 | 466.60 USD |
| 2/23/2026 | 468.32 USD |
| 2/22/2026 | 478.54 USD |
| 2/20/2026 | 475.41 USD |
| 2/19/2026 | 475.41 USD |
| 2/18/2026 | 472.11 USD |
| 2/17/2026 | 467.65 USD |
| 2/16/2026 | 473.06 USD |
| 2/13/2026 | 473.22 USD |
| 2/12/2026 | 473.22 USD |
| 2/11/2026 | 463.95 USD |
| 2/10/2026 | 462.89 USD |
| 2/9/2026 | 452.00 USD |
| 2/8/2026 | 448.17 USD |
| 2/6/2026 | 447.74 USD |
| 2/5/2026 | 447.74 USD |
| 2/4/2026 | 453.40 USD |
| 2/3/2026 | 443.76 USD |
| 2/2/2026 | 433.11 USD |
| 2/1/2026 | 435.27 USD |
| 1/30/2026 | 427.14 USD |
| 1/29/2026 | 427.14 USD |
| 1/28/2026 | 430.00 USD |
| 1/27/2026 | 432.56 USD |
| 1/26/2026 | 436.72 USD |
| 1/25/2026 | 448.03 USD |
| 1/23/2026 | 446.77 USD |
| 1/22/2026 | 446.77 USD |
| 1/21/2026 | 444.74 USD |
| 1/20/2026 | 453.53 USD |
| 1/19/2026 | 449.59 USD |
| 1/16/2026 | 451.90 USD |
| 1/15/2026 | 451.90 USD |
| 1/14/2026 | 458.93 USD |
| 1/13/2026 | 451.82 USD |
| 1/12/2026 | 448.44 USD |
| 1/11/2026 | 446.15 USD |
| 1/9/2026 | 444.40 USD |
| 1/8/2026 | 444.40 USD |
| 1/7/2026 | 449.18 USD |
| 1/6/2026 | 439.28 USD |
| 1/5/2026 | 441.09 USD |
| 1/4/2026 | 437.97 USD |
| 1/2/2026 | 423.79 USD |
| 1/1/2026 | 423.79 USD |
| 12/31/2025 | 427.86 USD |
| 12/30/2025 | 427.86 USD |
| 12/29/2025 | 430.82 USD |
| 12/28/2025 | 434.43 USD |
| 12/26/2025 | 432.18 USD |
| 12/25/2025 | 432.18 USD |
| 12/24/2025 | 435.28 USD |
| 12/23/2025 | 435.28 USD |
| 12/22/2025 | 432.66 USD |
| 12/21/2025 | 435.74 USD |
| 12/19/2025 | 435.33 USD |
| 12/18/2025 | 435.33 USD |
| 12/17/2025 | 430.24 USD |
| 12/16/2025 | 431.24 USD |
| 12/15/2025 | 429.13 USD |
| 12/14/2025 | 430.44 USD |
| 12/12/2025 | 430.06 USD |
| 12/11/2025 | 430.06 USD |
| 12/10/2025 | 429.16 USD |
| 12/9/2025 | 425.44 USD |
| 12/8/2025 | 420.48 USD |
| 12/7/2025 | 412.50 USD |
| 12/5/2025 | 421.97 USD |
| 12/4/2025 | 421.97 USD |
| 12/3/2025 | 424.30 USD |
| 12/2/2025 | 430.83 USD |
| 12/1/2025 | 429.54 USD |
| 11/30/2025 | 437.73 USD |
| 11/28/2025 | 439.19 USD |
| 11/27/2025 | 439.19 USD |
| 11/26/2025 | 441.36 USD |
| 11/25/2025 | 441.36 USD |
| 11/24/2025 | 440.70 USD |
| 11/23/2025 | 436.43 USD |
| 11/21/2025 | 441.74 USD |
| 11/20/2025 | 441.74 USD |
| 11/19/2025 | 429.33 USD |
| 11/18/2025 | 429.80 USD |
| 11/17/2025 | 435.33 USD |
| 11/16/2025 | 432.38 USD |
| 11/14/2025 | 435.56 USD |
| 11/13/2025 | 435.56 USD |
| 11/12/2025 | 446.01 USD |
| 11/11/2025 | 447.55 USD |
| 11/10/2025 | 445.53 USD |
| 11/9/2025 | 435.99 USD |
| 11/7/2025 | 434.61 USD |
| 11/6/2025 | 434.61 USD |
| 11/5/2025 | 430.59 USD |
| 11/4/2025 | 439.00 USD |
| 11/3/2025 | 439.09 USD |
| 11/2/2025 | 440.68 USD |
| 10/31/2025 | 431.30 USD |
| 10/30/2025 | 431.30 USD |
| 10/29/2025 | 454.44 USD |
| 10/28/2025 | 465.54 USD |
| 10/27/2025 | 438.94 USD |
| 10/26/2025 | 436.78 USD |
| 10/23/2025 | 436.62 USD |
| 10/22/2025 | 435.39 USD |
| 10/21/2025 | 439.30 USD |
| 10/20/2025 | 441.00 USD |
| 10/19/2025 | 444.95 USD |
| 10/16/2025 | 440.56 USD |
| 10/15/2025 | 430.92 USD |
| 10/14/2025 | 436.29 USD |
| 10/13/2025 | 437.13 USD |
| 10/12/2025 | 429.66 USD |
| 10/9/2025 | 430.02 USD |
| 10/8/2025 | 431.41 USD |
| 10/7/2025 | 434.96 USD |
| 10/6/2025 | 436.08 USD |
| 10/5/2025 | 435.38 USD |
| 10/2/2025 | 443.49 USD |
| 10/1/2025 | 442.04 USD |
| 9/30/2025 | 440.64 USD |
| 9/29/2025 | 447.74 USD |
| 9/28/2025 | 452.13 USD |
| 9/25/2025 | 462.23 USD |
| 9/24/2025 | 450.46 USD |
| 9/23/2025 | 456.98 USD |
| 9/22/2025 | 453.90 USD |
| 9/21/2025 | 455.91 USD |
| 9/18/2025 | 452.25 USD |
| 9/17/2025 | 458.25 USD |
| 9/16/2025 | 457.36 USD |
| 9/15/2025 | 447.63 USD |
| 9/14/2025 | 442.24 USD |
| 9/11/2025 | 446.40 USD |
| 9/10/2025 | 457.89 USD |
| 9/9/2025 | 450.70 USD |
| 9/8/2025 | 462.75 USD |
| 9/7/2025 | 463.78 USD |
| 9/4/2025 | 465.63 USD |
| 9/3/2025 | 459.70 USD |
| 9/2/2025 | 459.63 USD |
| 9/1/2025 | 464.00 USD |
| 8/28/2025 | 457.95 USD |
| 8/27/2025 | 451.90 USD |
| 8/26/2025 | 455.33 USD |
| 8/25/2025 | 446.26 USD |
| 8/24/2025 | 456.00 USD |
| 8/21/2025 | 459.05 USD |
Chemed Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Chemed Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEB USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| DIVIDENDDIV.USD |
| DIVIDEND GROWTHDIV. GROWTH% |
| SHARESM |
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.41 | 1.46 | 1.54 | 1.58 | 1.67 | 1.78 | 1.94 | 2.08 | 2.14 | 2.13 | 2.26 | 2.43 | 2.53 | 2.72 | 2.88 | 3.01 |
| -1.19 | 3.04 | 5.98 | 2.14 | 5.71 | 6.96 | 8.75 | 7.28 | 2.89 | -0.23 | 6.09 | 7.38 | 4.03 | 7.55 | 5.96 | 4.58 |
| 28.59 | 28.91 | 29.49 | 29.25 | 30.97 | 31.14 | 31.84 | 33.72 | 35.95 | 35.85 | 35.25 | 35.13 | 29.97 | 29.97 | 29.97 | 29.97 |
| 404.00 | 421.00 | 455.00 | 461.00 | 516.00 | 555.00 | 617.00 | 701.00 | 769.00 | 765.00 | 798.00 | 854.00 | 758.00 | 815.25 | 863.80 | 903.37 |
| 133.00 | 168.00 | 184.00 | 178.00 | 121.00 | 243.00 | 261.00 | 391.00 | 344.00 | 343.00 | 342.00 | 366.00 | 338.00 | 421.00 | 447.00 | 472.00 |
| 9.41 | 11.54 | 11.92 | 11.29 | 7.26 | 13.64 | 13.47 | 18.81 | 16.08 | 16.07 | 15.11 | 15.06 | 13.36 | 15.48 | 15.51 | 15.66 |
| 77.00 | 99.00 | 110.00 | 108.00 | 98.00 | 205.00 | 219.00 | 319.00 | 268.00 | 249.00 | 272.00 | 301.00 | 265.00 | 387.00 | 417.00 | 438.00 |
| -13.48 | 28.57 | 11.11 | -1.82 | -9.26 | 109.18 | 6.83 | 45.66 | -15.99 | -7.09 | 9.24 | 10.66 | -11.96 | 46.04 | 7.75 | 5.04 |
| 0.76 | 0.84 | 0.92 | 1.00 | 1.08 | 1.16 | 1.24 | 1.32 | 1.40 | 1.48 | 1.56 | 1.80 | 2.20 | 2.53 | 2.81 | 3.11 |
| 11.76 | 10.53 | 9.52 | 8.70 | 8.00 | 7.41 | 6.90 | 6.45 | 6.06 | 5.71 | 5.41 | 15.38 | 22.22 | 15.00 | 11.07 | 10.68 |
| 17.90 | 17.47 | 17.37 | 16.60 | 16.78 | 16.67 | 16.57 | 16.35 | 15.51 | 15.05 | 15.27 | 14.99 | 13.99 | 13.99 | 13.99 | 13.99 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Chemed generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Chemed retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Chemed's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Chemed has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Chemed's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Chemed stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Chemed Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Chemed business model & stock analysis
Chemed SWOT Analysis
Strengths
Chemed Corp possesses several key strengths that contribute to its success:
- Strong brand reputation
- Diverse portfolio of services
- Experienced and skilled workforce
- High customer satisfaction
Weaknesses
Despite its strengths, Chemed Corp also faces certain weaknesses:
- Dependence on a few major customers
- Limited geographical reach
- Reliance on regulatory approvals
- Higher prices compared to competitors
Opportunities
Chemed Corp can explore several opportunities to further grow its business:
- Expansion into new markets
- Acquisition of complementary businesses
- Increased demand for healthcare services
- Technological advancements in the industry
Threats
Chemed Corp should also be aware of potential threats that may impact its operations:
- Intense competition in the healthcare sector
- Changes in government regulations
- Economic downturns affecting consumer spending
- Labor shortages and rising labor costs
Chemed Employees
3 Years
5 Years
10 Years
25 Years
Max
Details
Chemed Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Chemed historical P/E ratio, EBIT multiple, and P/S ratio
Chemed annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Chemed shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Chemed stock splits
Chemed Dividend History
37 years of dividend payments · 17 consecutive increases
Chemed dividend history and estimates
3 Years
5 Years
10 Years
25 Years
Max
Details
Chemed dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Chemed forecasts and price targets in August 2026
Analyst Price Targets 2026Chemed Analyst Rating Actions
| Date | Firm | Action | Rating | Reliability |
|---|---|---|---|---|
| 7/31/2026 | Maintained | Outperform | 61 | |
| 7/30/2026 | Maintained | Sector Perform | 48 | |
| 7/9/2026 | Maintained | Neutral | 67 | |
| 4/27/2026 | Maintained | Sector Perform | 48 | |
| 2/27/2026 | Downgrade | OutperformSector Perform | 48 | |
| 2/27/2026 | Maintained | Outperform | 61 | |
| 1/22/2026 | Downgrade | BuyHold | 57 | |
| 11/10/2025 | Maintained | Outperform | 48 | |
| 9/10/2025 | Maintained | Buy | 67 | |
| 9/2/2025 | Upgrade | HoldBuy | 57 |
Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.
Chemed Earnings Calls
Chemed Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 7/28/2026 | 5.66USD | - | 671.69 MUSD | - | 2026 Q2 |
| 4/23/2026 | 5.36USD | - | 656.32 MUSD | - | 2026 Q1 |
| 2/25/2026 | 7.14USD | - | 665.68 MUSD | - | 2025 Q4 |
| 4/24/2024 | 5.50USD | - | 594.46 MUSD | - | 2024 Q1 |
| 2/21/2024 | 6.31USD | - | 592.51 MUSD | - | 2023 Q4 |
| 7/25/2023 | 5.02USD | - | 556.76 MUSD | - | 2023 Q2 |
| 4/24/2023 | 4.71USD | - | 548.66 MUSD | - | 2023 Q1 |
| 2/22/2023 | 5.37USD | - | 554.80 MUSD | - | 2022 Q4 |
| 10/31/2022 | 4.69USD | - | 534.96 MUSD | - | 2022 Q3 |
| 7/27/2022 | 4.82USD | - | 546.14 MUSD | - | 2022 Q2 |
EESG©
Eulerpool ESG Scorecard© for the Chemed stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Chemed shareholder structure
| % | Name |
|---|---|
8.80212% | |
5.37139% | |
4.18853% | |
3.29901% | |
3.04340% | |
2.73681% |
Chemed Beneficial Ownership Filings (SEC 13D/G)
| Stake | Holder | Filing |
|---|---|---|
11.31% | SEC ↗ | |
9.40% | SEC ↗ | |
7.71% | SEC ↗ | |
7.70% | SEC ↗ | |
7.70% | SEC ↗ | |
7.70% | SEC ↗ | |
7.70% | SEC ↗ | |
7.70% | SEC ↗ | |
7.70% | SEC ↗ | |
7.32% | SEC ↗ |
Chemed Executives and Management Board
14 members · avg. age 65 · 14 % women
Mr. Kevin Mcnamara (71)
President, Chief Executive Officer, Director · since 1986
12.77 M USD
Management
Mr. Nicholas Westfall (46)
Executive Vice President
Mr. Michael Witzeman (54)
Chief Financial Officer, Vice President, Controller
Mr. Spencer Lee (69)
Executive Vice President · since 1999
Mr. Brian Judkins (44)
Vice President, Chief Legal Officer, Secretary
Board of Directors
Mr. George Walsh (79)
Independent Chairman of the Board
Mr. Patrick Grace (69)
Independent Director
Mr. Christopher Heaney (71)
Independent Director
Mr. Ron DeLyons (63)
Independent Director
Mr. John Mount (56)
Independent Director
Mr. Thomas Rice (74)
Independent Director
Chemed Supply Chain
Frequently asked questions about Chemed
The business model of Chemed Corp focuses on providing end-of-life care services through its subsidiaries, VITAS Healthcare and Roto-Rooter. Chemed Corp operates in two segments: VITAS, which offers hospice services to patients with life-limiting illnesses, and Roto-Rooter, a leading provider of plumbing and drain cleaning services. VITAS prioritizes compassionate care, aiming to enhance quality of life for patients and support their families. Roto-Rooter, on the other hand, provides essential plumbing solutions, specializing in emergency repairs, maintenance, and installation services. Chemed Corp's business model emphasizes delivering high-quality and specialized services in the healthcare and plumbing sectors, positioning itself as a reliable and trusted provider.
Chemed Corp is primarily active in the healthcare and service industries.
The main competitors of Chemed Corp in the market include companies such as Amedisys Inc, Brookdale Senior Living Inc, and Encompass Health Corporation.
Chemed Corp is a renowned company with a rich history and compelling background. Established in 1970, Chemed Corp began as a provider of plumbing and drain cleaning services through its Roto-Rooter subsidiary. Over the years, it expanded its operations and diversified into healthcare services. Currently, Chemed Corp is a leading provider of hospice and palliative care services through its subsidiary, VITAS Healthcare. The corporation's commitment to exceptional patient care has earned it a stellar reputation in the healthcare industry. Chemed Corp continues to grow and flourish, upholding its core values and consistently delivering outstanding services to those in need.
Chemed Corp has achieved several significant milestones throughout its history. The company experienced strong growth and expanded its services, becoming a leader in the healthcare industry. Chemed Corp's subsidiary, VITAS Healthcare, has reached noteworthy achievements, including the provision of compassionate end-of-life care to thousands of patients and their families. Additionally, Chemed Corp successfully acquired and integrated various companies, enhancing its business portfolio and market presence. The company's commitment to innovation, quality care, and strategic acquisitions has contributed to its continued success and recognition within the industry.
Chemed Corp is primarily present in the United States.
Chemed Corp is a company known for exemplifying values of integrity, excellence, and innovation. With a strong corporate philosophy, Chemed prioritizes a customer-centric approach, constantly striving to meet and exceed their expectations. Their commitment to ethical practices and the highest standards in healthcare services distinguish them in the industry. Chemed also emphasizes the importance of fostering a positive work environment, valuing their employees and promoting professional growth. By consistently delivering exceptional results, Chemed reflects a dedication to long-term success and sustainable progress.
Analysts currently set an average price target of 566.61 USD for the Chemed stock (median: 587.52 USD), implying +5.9 % versus the latest price. The consensus is based on 8 analyst ratings.
8 analysts currently rate the Chemed stock: 6 recommend buying, 2 holding and 0 selling. For 2026, analysts expect Chemed to generate revenue of 2.72 B USD and earnings per share of 27.70 USD.
Converted at the current exchange rate, the Chemed share trades at 456.34 EUR (533.09 USD).
The Chemed share (CHE) is listed on 2 stock exchanges, including: NYSE (CHE), Frankfurt (CXM.F).
Chemed Corp is a US-based company operating in the hospice and drain cleaning sectors. It was founded in 1970 and is headquartered in Cincinnati, Ohio. Hospice services: Chemed Corp is the parent company of Vitas Healthcare, one of the largest hospice providers in the US. Vitas Healthcare offers a wide range of services for patients with life-threatening illnesses, including home care, support for family members and caregivers, pain therapy, and emotional support. Vitas Healthcare has a nationwide network of hospice centers and is a preferred hospice provider for Medicare, Medicaid, and private insurance companies. The company has also built partnerships with hospitals and nursing facilities to provide its customers access to top-quality care. Drain cleaning services: Chemed Corp also operates Roto-Rooter, one of the leading drain cleaning and plumbing companies in North America. The company offers a wide range of services, including pipe cleaning, sewer rehabilitation, and inspections of residential and commercial areas. Roto-Rooter is available 24/7 and offers emergency services. The company has also built a network of franchisees offering their services in multiple countries worldwide. Other business areas: In addition, Chemed Corp also operates milk production management consulting through its subsidiary Agri-Best. The company provides consulting services for dairy farms and assists with diets and feeding plans for dairy cows, among other services. Products: Chemed Corp offers a wide range of products for the hospice and drain cleaning sectors. For example, Vitas Healthcare offers medical supply products for customers and their environments, including respiratory aids, medical devices, and infusion pumps. Roto-Rooter offers plumbing products such as drain cleaners and pipes. Summary: Chemed Corp is a company operating in the hospice and drain cleaning sectors. The company offers a wide range of services and operates subsidiaries such as Vitas Healthcare and Roto-Rooter. Chemed Corp is also active in other business areas such as dairy management. The company offers a variety of products relevant to its different business sectors.
The expected revenue of Chemed is 2.72 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Chemed is 387.58 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Chemed is currently 19.25. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Chemed stock.
The price-to-sales ratio (P/S) of Chemed is currently 2.74. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Chemed stock.
The Eulerpool Quality Score for Chemed is 6/10.
The ISIN of Chemed is US16359R1032. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Chemed is A0CBF4. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Chemed is CHE. The ticker symbol is used to trade Chemed shares on the stock exchange.
Over the past 12 months, Chemed paid a dividend of 2.20 USD . This corresponds to a dividend yield of about 0.41 %. For the coming 12 months, Chemed is expected to pay a dividend of 2.66 USD.
The current dividend yield of Chemed is 0.41 %.
Chemed pays a dividend, distributed in the months of , , , .
Chemed paid dividends every year for the past 36 years.
For the upcoming 12 months, dividends amounting to 2.66 USD are expected. This corresponds to a dividend yield of 0.50 %.
Chemed is assigned to the 'Health' sector.
To receive the latest dividend of Chemed from amounting to 0.6 USD, you needed to have the stock in your portfolio before the ex-date on .
The last dividend was paid out on .
In the year 2025, Chemed distributed 1.8 USD as dividends.
The dividends of Chemed are distributed in USD.
Chemed stock
Chemed Peer Group
Chemed Ticker
Chemed FIGI
All fundamentals and in-depth analysis of Chemed
Our stock analysis for Chemed stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chemed. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.